サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1428046

組織マイクロアレイの世界市場レポート 2024

Tissue Microarray Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
組織マイクロアレイの世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

組織マイクロアレイの市場規模は、今後数年間で急速に成長すると予想されています。 2028年には10.9%の年間複合成長率（CAGR）で186億8,000万米ドルに成長すると予想されます。予測期間で予想される成長は、デジタルパソロジーの出現、組織マイクロアレイの適用範囲の拡大、バイオ医薬品業界の成長、規制上のサポートと基準、人工知能（AI）と機械学習の統合などの要因に起因すると考えられます。予測期間における注目すべき動向には、イメージング技術の進歩、3D 組織マイクロアレイの開発、ハイコンテンツスクリーニングの採用、標準化への取り組み、および単一細胞分析法の統合が含まれます。

組織マイクロアレイ市場は、がん症例数の増加により成長する態勢が整っています。異常な細胞増殖と浸潤を特徴とするがんには、高度な診断ツールが必要です。組織アレイは、さまざまな腫瘍サンプル中のがん関連バイオマーカーを検査することにより、腫瘍学において重要な役割を果たします。 American Cancer Society Inc.によると、2022年に米国ではがんによる死亡者数が609,820人、新たながん患者数が1,958,310人になると推定されており、がんの調査と診断における組織マイクロアレイの需要が浮き彫りになっています。

組織マイクロアレイ市場の成長は、個別化医療に対する需要の高まりによってさらに加速されています。個別化医療は、より効果的なヘルスケアを調整します。 組織マイクロアレイは、複数の組織サンプルを同時に分析するのに役立ち、バイオマーカーの迅速な評価を促進します。 2022年、食品医薬品局の医薬品評価研究センター（CDER）は37の新しい分子実体（NME）を承認し、そのうち約34%が個別化医療として分類されました。これは、個別化医療の推進における組織マイクロアレイの不可欠な役割を強調しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の組織マイクロアレイ市場促進要因と制約要因
    • 市場の促進要因
    • 市場の抑制要因
  • 世界の組織マイクロアレイ市場規模実績と成長、2018年から2023年
  • 世界の組織マイクロアレイ市場規模と成長予測、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界の組織マイクロアレイ市場、タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 免疫組織化学
  • 蛍光In situハイブリダイゼーション
  • 凍結組織アレイ
  • その他のタイプ
  • 世界の組織マイクロアレイ市場、技術別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • デオキシリボ核酸（DNA）マイクロアレイ
  • ポリメラーゼ連鎖反応（PCR）
  • 次世代シーケンス
  • ノーザンブロッティング
  • ウェスタンブロッティング
  • 世界の組織マイクロアレイ市場、アプリケーション別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 腫瘍学
  • 遺伝子発現プロファイリング
  • 一塩基多型（SNP）の検出
  • 二本鎖B-DNAマイクロアレイ
  • 比較ゲノムハイブリダイゼーション
  • シーケンスバイオインフォマティクス
  • 世界の組織マイクロアレイ市場、エンドユーザー別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 製薬会社およびバイオテクノロジー会社
  • 調査機関
  • 病院

第7章 地域および国の分析

  • 世界の組織マイクロアレイ市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界の組織マイクロアレイ市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 組織マイクロアレイ市場の競合情勢
  • 組織マイクロアレイ市場の企業プロファイル
    • Roche Group
    • Merck &Co. Inc.
    • Thermo Fisher Scientific Inc.
    • Becton, Dickinson Biosciences
    • Agilent Technologies Inc.

第31章 その他の大手および革新的な企業

  • Illumina Inc.
  • Bio-Rad Laboratories Inc.
  • Qiagen NV
  • PerkinElmer Inc.
  • Bio-Techne Corporation
  • Tristar Group
  • Evotec SE
  • Precision For Medicine Inc.
  • Molecular Devices LLC
  • BioIVT LLC
  • BioChain Institute Inc.
  • Creative Bioarray Co
  • 3DHISTECH Ltd.
  • Novus Biologicals LLC
  • OriGene Technologies Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r13890

A tissue microarray is a high-throughput technology that enables comprehensive analysis of antigen expression across numerous tissues and cells in a single experiment, typically using paraffin blocks or formalin. It allows for the simultaneous assessment of protein expression in multiple tissue samples.

The primary types of tissue microarrays include immunohistochemistry, fluorescent in situ hybridization, frozen tissue array, and other variants. Immunohistochemistry (IHC) is a technique used to diagnose certain types of cancer, such as mesothelioma, by employing a visual marker to locate antigens in biopsy tissue. Various technologies such as DNA microarrays, polymerase chain reaction (PCR), next-generation sequencing, northern blotting, western blotting, and others are utilized for applications in oncology, gene expression profiling, single nucleotide polymorphism (SNP) detection, double-stranded B-DNA microarrays, comparative genomic hybridization, sequencing bioinformatics, and more. These technologies find applications across different end-users, including pharmaceutical and biotechnological companies, research organizations, and hospitals.

The tissue microarray research report is one of a series of new reports from The Business Research Company that provides tissue microarray market statistics, including the tissue microarray industry's global market size, regional shares, competitors with tissue microarray market share, detailed tissue microarray market segments, market trends and opportunities, and any further data you may need to thrive in the tissue microarray industry. This tissue microarray market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The tissue microarray market size has grown rapidly in recent years. It will grow from $11.17 billion in 2023 to $12.36 billion in 2024 at a compound annual growth rate (CAGR) of 10.7%. The growth observed in the historical period can be attributed to factors such as the rise of precision medicine, advancements in drug discovery and development, the efficient analysis enabled by tissue microarrays, the increasing prevalence of chronic diseases, and initiatives in biobanking.

The tissue microarray market size is expected to see rapid growth in the next few years. It will grow to $18.68 billion in 2028 at a compound annual growth rate (CAGR) of 10.9%. The anticipated growth in the forecast period can be attributed to factors such as the emergence of digital pathology, expanded applications of tissue microarrays, the growth of the biopharmaceutical industry, regulatory support and standards, and the integration of artificial intelligence (AI) and machine learning. Noteworthy trends in the forecast period include advancements in imaging technologies, the development of 3D tissue microarrays, the adoption of high-content screening, standardization initiatives, and the integration of single-cell analysis methods.

The tissue microarray market is poised for growth, driven by the increasing number of cancer cases. Cancer, characterized by abnormal cell proliferation and invasion, necessitates advanced diagnostic tools. Tissue arrays play a crucial role in oncology by examining cancer-related biomarkers in various tumor samples. According to the American Cancer Society Inc., it is estimated that there will be 609,820 cancer deaths and 1,958,310 new cancer cases in the US during 2022, underscoring the demand for tissue microarrays in cancer research and diagnosis.

The growth of the tissue microarray market is further fueled by the rising demand for personalized medicine. Personalized medicine tailors medical treatment to individual characteristics for more effective healthcare. Tissue microarrays are instrumental in analyzing multiple tissue samples concurrently, facilitating rapid assessment of biomarkers. In 2022, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs), with approximately 34% classified as personalized medicines. This emphasizes the integral role of tissue microarrays in advancing personalized medicine.

A notable trend in the tissue microarray market is the emergence of strategic partnerships. Major companies in the market are forming alliances to develop innovative tissue microarray technologies. For instance, The Cureline Group partnered with Cellecta Inc. to launch Tissue 2 Target Services, combining their competencies in molecular analysis and biospecimen management. Another collaboration involves Ultivue Inc. and ngTMA, aiming to advance multiplexed immunofluorescence assays and apply new tissue microarray technologies for spatial analysis in scientific research.

Companies in the tissue microarray market are focusing on advanced solutions, such as microarray platforms, to enhance precision and efficiency in high-throughput tissue analysis. MARGenomics launched the Applied Biosystems GeneChip 3000 Dx v2, an advanced microarray platform, the first in Europe and the United States to receive regulatory approval for diagnostic purposes. This platform, funded by the Carlos III Health Institute and the European Union's NextGenerationEU initiative, offers diverse functionalities for genomic and expression microarrays.

In July 2021, BioIVT acquired Tissue Solutions Ltd., expanding access to high-quality disease state and control biospecimens. Tissue Solutions Ltd., a virtual biobank based in the UK, provides human tissue and biological materials to researchers for various applications, including drug discovery, target identification, assay creation, and biomarker development. This acquisition enhances BioIVT's capabilities and geographic reach with an addition of 150 collection sites.

Major companies operating in the tissue microarray market report are Roche Group, Merck & Co. Inc., Thermo Fisher Scientific Inc., Becton, Dickinson Biosciences, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Qiagen NV, PerkinElmer Inc., Bio-Techne Corporation, Tristar Group, Evotec SE, Precision For Medicine Inc., Molecular Devices LLC, BioIVT LLC, BioChain Institute Inc., Creative Bioarray Co, 3DHISTECH Ltd., Novus Biologicals LLC, OriGene Technologies Inc., PREMIER Biosoft International Inc., iSpecimen Inc., OriGene Technologies Inc., Bio SB Inc., ProteoGenex Inc., Z Biotech LLC

North America was the largest region in the tissue microarray market in 2023. Asia-Pacific is expected to be the fastest-growing region in the tissue microarray market report during the forecast period. The regions covered in the tissue microarray market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the tissue microarray market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tissue microarray market consists of sales of molds, needles, and tissue punches. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tissue Microarray Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tissue microarray market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tissue microarray ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tissue microarray market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Immunohistochemistry; Fluorescent In Situ Hybridization; Frozen Tissue Array; Other Types
  • 2) By Technology: Deoxyribonucleic Acid (DNA) Microarray; Polymerase Chain Reaction (PCR); Next-Generation Sequencing; Northern Blotting; Western Blotting
  • 3) By Application: Oncology; Gene Expression Profiling; Single Nucleotide Polymorphism (SNP) Detection; Double-Stranded B-DNA Microarrays; Comparative Genomic Hybridization; Sequencing Bioinformatics
  • 4) By End-User: Pharmaceutical And Biotechnological Companies; Research Organization; Hospitals
  • Companies Mentioned: Roche Group; Merck & Co. Inc.; Thermo Fisher Scientific Inc.; Becton, Dickinson Biosciences; Agilent Technologies Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tissue Microarray Market Characteristics

3. Tissue Microarray Market Trends And Strategies

4. Tissue Microarray Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Tissue Microarray Market Size and Growth

  • 5.1. Global Tissue Microarray Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Tissue Microarray Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Tissue Microarray Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Tissue Microarray Market Segmentation

  • 6.1. Global Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Immunohistochemistry
  • Fluorescent In Situ Hybridization
  • Frozen Tissue Array
  • Other Types
  • 6.2. Global Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Deoxyribonucleic Acid (DNA) Microarray
  • Polymerase Chain Reaction (PCR)
  • Next-Generation Sequencing
  • Northern Blotting
  • Western Blotting
  • 6.3. Global Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oncology
  • Gene Expression Profiling
  • Single Nucleotide Polymorphism (SNP) Detection
  • Double-Stranded B-DNA Microarrays
  • Comparative Genomic Hybridization
  • Sequencing Bioinformatics
  • 6.4. Global Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pharmaceutical And Biotechnological Companies
  • Research Organization
  • Hospitals

7. Tissue Microarray Market Regional And Country Analysis

  • 7.1. Global Tissue Microarray Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Tissue Microarray Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Tissue Microarray Market

  • 8.1. Asia-Pacific Tissue Microarray Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Tissue Microarray Market

  • 9.1. China Tissue Microarray Market Overview
  • 9.2. China Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Tissue Microarray Market

  • 10.1. India Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Tissue Microarray Market

  • 11.1. Japan Tissue Microarray Market Overview
  • 11.2. Japan Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Tissue Microarray Market

  • 12.1. Australia Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Tissue Microarray Market

  • 13.1. Indonesia Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Tissue Microarray Market

  • 14.1. South Korea Tissue Microarray Market Overview
  • 14.2. South Korea Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Tissue Microarray Market

  • 15.1. Western Europe Tissue Microarray Market Overview
  • 15.2. Western Europe Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Tissue Microarray Market

  • 16.1. UK Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Tissue Microarray Market

  • 17.1. Germany Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Tissue Microarray Market

  • 18.1. France Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Tissue Microarray Market

  • 19.1. Italy Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Tissue Microarray Market

  • 20.1. Spain Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Tissue Microarray Market

  • 21.1. Eastern Europe Tissue Microarray Market Overview
  • 21.2. Eastern Europe Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Tissue Microarray Market

  • 22.1. Russia Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Tissue Microarray Market

  • 23.1. North America Tissue Microarray Market Overview
  • 23.2. North America Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Tissue Microarray Market

  • 24.1. USA Tissue Microarray Market Overview
  • 24.2. USA Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Tissue Microarray Market

  • 25.1. Canada Tissue Microarray Market Overview
  • 25.2. Canada Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Tissue Microarray Market

  • 26.1. South America Tissue Microarray Market Overview
  • 26.2. South America Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Tissue Microarray Market

  • 27.1. Brazil Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Tissue Microarray Market

  • 28.1. Middle East Tissue Microarray Market Overview
  • 28.2. Middle East Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Tissue Microarray Market

  • 29.1. Africa Tissue Microarray Market Overview
  • 29.2. Africa Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Tissue Microarray Market Competitive Landscape And Company Profiles

  • 30.1. Tissue Microarray Market Competitive Landscape
  • 30.2. Tissue Microarray Market Company Profiles
    • 30.2.1. Roche Group
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Merck & Co. Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Thermo Fisher Scientific Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Becton, Dickinson Biosciences
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Agilent Technologies Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Tissue Microarray Market Other Major And Innovative Companies

  • 31.1. Illumina Inc.
  • 31.2. Bio-Rad Laboratories Inc.
  • 31.3. Qiagen NV
  • 31.4. PerkinElmer Inc.
  • 31.5. Bio-Techne Corporation
  • 31.6. Tristar Group
  • 31.7. Evotec SE
  • 31.8. Precision For Medicine Inc.
  • 31.9. Molecular Devices LLC
  • 31.10. BioIVT LLC
  • 31.11. BioChain Institute Inc.
  • 31.12. Creative Bioarray Co
  • 31.13. 3DHISTECH Ltd.
  • 31.14. Novus Biologicals LLC
  • 31.15. OriGene Technologies Inc.

32. Global Tissue Microarray Market Competitive Benchmarking

33. Global Tissue Microarray Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Tissue Microarray Market

35. Tissue Microarray Market Future Outlook and Potential Analysis

  • 35.1 Tissue Microarray Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Tissue Microarray Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Tissue Microarray Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer